Evidence map›Paper›PMID 39276773›Full record

ArticleCell2024

A developmental gradient reveals biosynthetic pathways to eukaryotic toxins in monocot geophytes.

Niraj Mehta, Yifan Meng, Richard Zare, Rina Kamenetsky-Goldstein, Elizabeth Sattely

Abstract read
In one paragraph

Article in Cell, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Two roads to galanthamine turn out to be one.The Plant journal : for cell and molecular biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Niraj MehtaDepartment of Chemistry, Stanford University, Stanford, CA 94305, USA.
Yifan MengDepartment of Chemistry, Stanford University, Stanford, CA 94305, USA.
Richard ZareDepartment of Chemistry, Stanford University, Stanford, CA 94305, USA.
Rina Kamenetsky-GoldsteinInstitute of Plant Sciences, ARO, The Volcani Center, Rishon LeZion, Israel.
Elizabeth SattelyDepartment of Chemical Engineering, Stanford University, Stanford, CA 94305, USA; HHMI, Stanford University, Stanford, CA 94305, USA. Electronic address: sattely@stanford.edu.

Funding

Discovery and Engineering of Plant Natural Product PathwaysR01GM121527 · NIGMS · STANFORD UNIVERSITY · PI SATTELY, ELIZABETH SUSAN · 2017 to 2025
$2.3M
NIGMS NIH HHS R01 GM121527
6 · The paper itself

Abstract

Numerous eukaryotic toxins that accumulate in geophytic plants are valuable in the clinic, yet their biosynthetic pathways have remained elusive. A notable example is the >150 Amaryllidaceae alkaloids (AmAs), including galantamine, an FDA-approved treatment for Alzheimer's disease. We show that while AmAs accumulate to high levels in many daffodil tissues, biosynthesis is localized to nascent, growing tissue at the leaf base. A similar trend is found in the production of steroidal alkaloids (e.g., cyclopamine) in corn lily. This model of active biosynthesis enabled the elucidation of a complete set of biosynthetic genes that can be used to produce AmAs. Taken together, our work sheds light on the developmental and enzymatic logic of diverse alkaloid biosynthesis in daffodils. More broadly, it suggests a paradigm for biosynthesis regulation in monocot geophytes, where plants are protected from herbivory through active charging of newly formed cells with eukaryotic toxins that persist as above-ground tissue develops.

Indexed as

Biosynthetic PathwaysAlkaloidsAmaryllidaceaePlant LeavesToxins, BiologicalAlkaloidsToxins, Biologicalbiosynthesismetabolismmonocotsplant toxins

Identifiers

PMID39276773
PMCPMC11893076

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.